Liquid Biopsy Market Growth, Trend, Price, Demand and Forecast Liquid Biopsy Market - Global Industry Analysis, S | Page 2

with cutting edge technologies, increasing research and development funding/investments, and rising
demand in academic and research institutes.
Unmet medical needs in the field of cancer treatment and focus on reducing cancer mortalities by
providing a broad-spectrum assay with less cumbersome method present significant opportunities in
the global liquid biopsy market. The advantages of liquid biopsy over traditional solid biopsy, increasing
focus and collaborations among major market players, and research institutes for the generation of
multi-regimen assays are fueling the growth of the market.
Key players in the global liquid biopsy market are QIAGEN, RainDance Technologies, Inc., F.
Hoffmann-La Roche Ltd., Trovagene, Bio-Rad Laboratories, Inc., Genomic Health, Myriad Genetics,
Inc., Biocept, Inc., Johnson & Johnson (Janssen Global Services, LLC), Illumina, Inc., and MDxHealth,
among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The projections featured in the report have
been derived using proven research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of the market, including but not
limited to: Regional markets, technology, types, and applications.
Browse full report @ http://www.transparencymarketresearch.com/liquid-biopsy-market.html
The study is a source of reliable data on:








Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
The regional analysis covers:






North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Ger